![James Caruso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Caruso
Vorstandsvorsitzender bei
CELLECTAR BIOSCIENCES, INC.
Vermögen: 36 543 $ am 31.05.2026
Profil
Mr. James V.
Caruso is a President, Chief Executive Officer & Director at Cellectar Biosciences, Inc. He is on the Board of Directors at Cellectar Biosciences, Inc. and Hip Innovation Technology LLC.
Mr. Caruso was previously employed as a Chief Commercial Officer & Executive VP by Allos Therapeutics, Inc., a Senior Vice President-Sales & Marketing by Bone Care International, Inc., a Vice President-Neuroscience Specialty Sales by Novartis Corp., a Vice President-Primary & Specialty Sales by BASF Pharma Ltd., and a Vice President-Sales by Knoll Pharmaceutical Co. He received his undergraduate degree from the University of Nevada.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.05.2026 | 11 638 ( 0,15 % ) | 36 543 $ | 31.05.2026 |
Aktive Positionen von James Caruso
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Vorstandsvorsitzender | 15.06.2015 |
Hip Innovation Technology LLC
 Hip Innovation Technology LLC Medical DistributorsDistribution Services Sells hip implant systems and components | Gründer | 01.08.2010 |
Ehemalige bekannte Positionen von James Caruso
| Unternehmen | Position | Ende |
|---|---|---|
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Corporate Officer/Principal | 24.08.2010 |
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Vertrieb & Marketing | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Vertrieb & Marketing | 01.06.2002 |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces excipients and active ingredients | Vertrieb & Marketing | 01.05.2001 |
Knoll Pharmaceutical Co. | Vertrieb & Marketing | 01.01.2001 |
Ausbildung von James Caruso
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
43
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Hip Innovation Technology LLC
Hip Innovation Technology LLC Medical DistributorsDistribution Services Sells hip implant systems and components | Distribution Services |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces excipients and active ingredients | Health Technology |
University of Nevada
 University of Nevada Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Knoll Pharmaceutical Co. | |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
